Global PSMA-Targeted PET Imaging Agent Market Growth 2026-2032
The global PSMA-Targeted PET Imaging Agent market size is predicted to grow from US$ 1731 million in 2025 to US$ 2839 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.
In 2025, the global production of PSMA?targeted PET imaging agents reached 3,539,400 vials, with an average selling price of US$500 per vial. The global annual production capacity of PSMA?targeted PET imaging agents was approximately 5 million vials, and the gross margin was about 30.4%. A PSMA?targeted PET imaging agent is a radiopharmaceutical that utilizes prostate?specific membrane antigen (PSMA) as a molecular target and is imaged via positron emission tomography (PET). Its core structure consists of two components: a targeting ligand (such as PSMA?11, PSMA?617, PSMA?1007, or other small molecules or peptides) that specifically recognizes and binds to PSMA protein, and a positron?emitting radionuclide (such as ??Ga, ??F, etc.) attached to the ligand. After injection into the human body, the imaging agent selectively accumulates in prostate cancer lesions and metastatic sites, and PET scanning generates three?dimensional images with high sensitivity and high resolution to reveal tumor distribution. It is mainly used for initial staging of prostate cancer, localization of lesions after biochemical recurrence, and guidance for individualized treatment decisions. The upstream of PSMA?targeted PET imaging agents includes radionuclides (e.g., gallium?68, fluorine?18), PSMA?targeting ligands (small molecules, peptides, or antibodies), and nanocarriers/chelating agents. The midstream consists of manufacturers of PSMA?targeted PET imaging agents, and the downstream is primarily applied in nuclear medicine and molecular imaging, precision diagnosis of tumors, and radiopharmaceuticals and nuclear medicine.
Currently, the market for PSMA?targeted PET imaging agents is experiencing sustained growth, driven fundamentally by the rising demand for precision medicine in prostate cancer and the deepening integration of molecular imaging with radiopharmaceutical technologies. Owing to their high affinity and specificity for the PSMA target, these imaging agents have gradually expanded their clinical utility from mainly detecting lesions in patients with biochemical recurrence to broader applications across the entire prostate cancer care continuum, including initial staging, treatment response assessment, and active surveillance, with their clinical acceptance and guideline recommendations notably strengthened. However, large?scale market development still faces challenges such as cold?chain logistics and just?in?time delivery pressures imposed by short radionuclide half?lives, variations in multi?site production quality control standards, and disparities across countries in regulatory approval, reimbursement policies, and radiation safety regulations. Meanwhile, technological advances are focusing on novel ligand design, expansion of radionuclide options (e.g., the shift from ??Ga to ??F), and integrated development under the theranostics concept. These innovations are not only broadening the indications but also shifting the competitive landscape from product?centric rivalry toward platform?based and comprehensive service capabilities. Overall, the industry is moving steadily toward greater precision, standardization, and accessibility.
LP Information, Inc. (LPI) ' newest research report, the “PSMA-Targeted PET Imaging Agent Industry Forecast” looks at past sales and reviews total world PSMA-Targeted PET Imaging Agent sales in 2025, providing a comprehensive analysis by region and market sector of projected PSMA-Targeted PET Imaging Agent sales for 2026 through 2032. With PSMA-Targeted PET Imaging Agent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PSMA-Targeted PET Imaging Agent industry.
This Insight Report provides a comprehensive analysis of the global PSMA-Targeted PET Imaging Agent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PSMA-Targeted PET Imaging Agent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PSMA-Targeted PET Imaging Agent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PSMA-Targeted PET Imaging Agent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PSMA-Targeted PET Imaging Agent.
This report presents a comprehensive overview, market shares, and growth opportunities of PSMA-Targeted PET Imaging Agent market by product type, application, key manufacturers and key regions and countries.
In 2025, the global production of PSMA?targeted PET imaging agents reached 3,539,400 vials, with an average selling price of US$500 per vial. The global annual production capacity of PSMA?targeted PET imaging agents was approximately 5 million vials, and the gross margin was about 30.4%. A PSMA?targeted PET imaging agent is a radiopharmaceutical that utilizes prostate?specific membrane antigen (PSMA) as a molecular target and is imaged via positron emission tomography (PET). Its core structure consists of two components: a targeting ligand (such as PSMA?11, PSMA?617, PSMA?1007, or other small molecules or peptides) that specifically recognizes and binds to PSMA protein, and a positron?emitting radionuclide (such as ??Ga, ??F, etc.) attached to the ligand. After injection into the human body, the imaging agent selectively accumulates in prostate cancer lesions and metastatic sites, and PET scanning generates three?dimensional images with high sensitivity and high resolution to reveal tumor distribution. It is mainly used for initial staging of prostate cancer, localization of lesions after biochemical recurrence, and guidance for individualized treatment decisions. The upstream of PSMA?targeted PET imaging agents includes radionuclides (e.g., gallium?68, fluorine?18), PSMA?targeting ligands (small molecules, peptides, or antibodies), and nanocarriers/chelating agents. The midstream consists of manufacturers of PSMA?targeted PET imaging agents, and the downstream is primarily applied in nuclear medicine and molecular imaging, precision diagnosis of tumors, and radiopharmaceuticals and nuclear medicine.
Currently, the market for PSMA?targeted PET imaging agents is experiencing sustained growth, driven fundamentally by the rising demand for precision medicine in prostate cancer and the deepening integration of molecular imaging with radiopharmaceutical technologies. Owing to their high affinity and specificity for the PSMA target, these imaging agents have gradually expanded their clinical utility from mainly detecting lesions in patients with biochemical recurrence to broader applications across the entire prostate cancer care continuum, including initial staging, treatment response assessment, and active surveillance, with their clinical acceptance and guideline recommendations notably strengthened. However, large?scale market development still faces challenges such as cold?chain logistics and just?in?time delivery pressures imposed by short radionuclide half?lives, variations in multi?site production quality control standards, and disparities across countries in regulatory approval, reimbursement policies, and radiation safety regulations. Meanwhile, technological advances are focusing on novel ligand design, expansion of radionuclide options (e.g., the shift from ??Ga to ??F), and integrated development under the theranostics concept. These innovations are not only broadening the indications but also shifting the competitive landscape from product?centric rivalry toward platform?based and comprehensive service capabilities. Overall, the industry is moving steadily toward greater precision, standardization, and accessibility.
LP Information, Inc. (LPI) ' newest research report, the “PSMA-Targeted PET Imaging Agent Industry Forecast” looks at past sales and reviews total world PSMA-Targeted PET Imaging Agent sales in 2025, providing a comprehensive analysis by region and market sector of projected PSMA-Targeted PET Imaging Agent sales for 2026 through 2032. With PSMA-Targeted PET Imaging Agent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PSMA-Targeted PET Imaging Agent industry.
This Insight Report provides a comprehensive analysis of the global PSMA-Targeted PET Imaging Agent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PSMA-Targeted PET Imaging Agent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PSMA-Targeted PET Imaging Agent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PSMA-Targeted PET Imaging Agent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PSMA-Targeted PET Imaging Agent.
This report presents a comprehensive overview, market shares, and growth opportunities of PSMA-Targeted PET Imaging Agent market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 68Ga
- 18F
Segmentation by Core Carrier Materials:
- First Generation
- Second Generation
Segmentation by Mechanism of Action:
- Active Targeting
- Passive Targeting
Segmentation by Application:
- Nuclear Medicine and Molecular Imaging
- Precision Oncology Diagnostics
- Radiopharmaceuticals and Radiopharmaceuticals
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lantheus
- Telix Pharmaceuticals
- Novartis
- Blue Earth Diagnostics?Bracco?
- Sinotau
- DC PHARMA
- Clarity Pharmaceuticals
- Hengrui Pharma
- CRAND PHARMACEUTICAL
- Norroy Bioscience
- HUAYI RADIOPHARMACEUTICALS
- Yunhe Pharma
- C Ray Therapeutics
- Curium Holding France S.A.S.
- ABX advanced biochemical compounds GmbH
- Isotopia Molecular Imaging Ltd.
Key Questions Addressed in this Report
- What is the 10-year outlook for the global PSMA-Targeted PET Imaging Agent market?
- What factors are driving PSMA-Targeted PET Imaging Agent market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do PSMA-Targeted PET Imaging Agent market opportunities vary by end market size?
- How does PSMA-Targeted PET Imaging Agent break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PSMA-Targeted PET Imaging Agent Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for PSMA-Targeted PET Imaging Agent by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for PSMA-Targeted PET Imaging Agent by Country/Region, 2021, 2025 & 2032
2.2 PSMA-Targeted PET Imaging Agent Segment by Type
2.2.1 68Ga
2.2.2 18F
2.2.3 PSMA-Targeted PET Imaging Agent Sales by Type
2.2.3.1 Global PSMA-Targeted PET Imaging Agent Sales Market Share by Type (2021-2026)
2.2.3.2 Global PSMA-Targeted PET Imaging Agent Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global PSMA-Targeted PET Imaging Agent Sale Price by Type (2021-2026)
2.3 PSMA-Targeted PET Imaging Agent Segment by Core Carrier Materials
2.3.1 First Generation
2.3.2 Second Generation
2.3.3 PSMA-Targeted PET Imaging Agent Sales by Core Carrier Materials
2.3.3.1 Global PSMA-Targeted PET Imaging Agent Sales Market Share by Core Carrier Materials (2021-2026)
2.3.3.2 Global PSMA-Targeted PET Imaging Agent Revenue and Market Share by Core Carrier Materials (2021-2026)
2.3.3.3 Global PSMA-Targeted PET Imaging Agent Sale Price by Core Carrier Materials (2021-2026)
2.4 PSMA-Targeted PET Imaging Agent Segment by Mechanism of Action
2.4.1 Active Targeting
2.4.2 Passive Targeting
2.4.3 PSMA-Targeted PET Imaging Agent Sales by Mechanism of Action
2.4.3.1 Global PSMA-Targeted PET Imaging Agent Sales Market Share by Mechanism of Action (2021-2026)
2.4.3.2 Global PSMA-Targeted PET Imaging Agent Revenue and Market Share by Mechanism of Action (2021-2026)
2.4.3.3 Global PSMA-Targeted PET Imaging Agent Sale Price by Mechanism of Action (2021-2026)
2.5 PSMA-Targeted PET Imaging Agent Segment by Application
2.5.1 Nuclear Medicine and Molecular Imaging
2.5.2 Precision Oncology Diagnostics
2.5.3 Radiopharmaceuticals and Radiopharmaceuticals
2.5.4 PSMA-Targeted PET Imaging Agent Sales by Application
2.5.4.1 Global PSMA-Targeted PET Imaging Agent Sale Market Share by Application (2021-2026)
2.5.4.2 Global PSMA-Targeted PET Imaging Agent Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global PSMA-Targeted PET Imaging Agent Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global PSMA-Targeted PET Imaging Agent Breakdown Data by Company
3.1.1 Global PSMA-Targeted PET Imaging Agent Annual Sales by Company (2021-2026)
3.1.2 Global PSMA-Targeted PET Imaging Agent Sales Market Share by Company (2021-2026)
3.2 Global PSMA-Targeted PET Imaging Agent Annual Revenue by Company (2021-2026)
3.2.1 Global PSMA-Targeted PET Imaging Agent Revenue by Company (2021-2026)
3.2.2 Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Company (2021-2026)
3.3 Global PSMA-Targeted PET Imaging Agent Sale Price by Company
3.4 Key Manufacturers PSMA-Targeted PET Imaging Agent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PSMA-Targeted PET Imaging Agent Product Location Distribution
3.4.2 Players PSMA-Targeted PET Imaging Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PSMA-TARGETED PET IMAGING AGENT BY GEOGRAPHIC REGION
4.1 World Historic PSMA-Targeted PET Imaging Agent Market Size by Geographic Region (2021-2026)
4.1.1 Global PSMA-Targeted PET Imaging Agent Annual Sales by Geographic Region (2021-2026)
4.1.2 Global PSMA-Targeted PET Imaging Agent Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic PSMA-Targeted PET Imaging Agent Market Size by Country/Region (2021-2026)
4.2.1 Global PSMA-Targeted PET Imaging Agent Annual Sales by Country/Region (2021-2026)
4.2.2 Global PSMA-Targeted PET Imaging Agent Annual Revenue by Country/Region (2021-2026)
4.3 Americas PSMA-Targeted PET Imaging Agent Sales Growth
4.4 APAC PSMA-Targeted PET Imaging Agent Sales Growth
4.5 Europe PSMA-Targeted PET Imaging Agent Sales Growth
4.6 Middle East & Africa PSMA-Targeted PET Imaging Agent Sales Growth
5 AMERICAS
5.1 Americas PSMA-Targeted PET Imaging Agent Sales by Country
5.1.1 Americas PSMA-Targeted PET Imaging Agent Sales by Country (2021-2026)
5.1.2 Americas PSMA-Targeted PET Imaging Agent Revenue by Country (2021-2026)
5.2 Americas PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026)
5.3 Americas PSMA-Targeted PET Imaging Agent Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PSMA-Targeted PET Imaging Agent Sales by Region
6.1.1 APAC PSMA-Targeted PET Imaging Agent Sales by Region (2021-2026)
6.1.2 APAC PSMA-Targeted PET Imaging Agent Revenue by Region (2021-2026)
6.2 APAC PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026)
6.3 APAC PSMA-Targeted PET Imaging Agent Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PSMA-Targeted PET Imaging Agent by Country
7.1.1 Europe PSMA-Targeted PET Imaging Agent Sales by Country (2021-2026)
7.1.2 Europe PSMA-Targeted PET Imaging Agent Revenue by Country (2021-2026)
7.2 Europe PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026)
7.3 Europe PSMA-Targeted PET Imaging Agent Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PSMA-Targeted PET Imaging Agent by Country
8.1.1 Middle East & Africa PSMA-Targeted PET Imaging Agent Sales by Country (2021-2026)
8.1.2 Middle East & Africa PSMA-Targeted PET Imaging Agent Revenue by Country (2021-2026)
8.2 Middle East & Africa PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026)
8.3 Middle East & Africa PSMA-Targeted PET Imaging Agent Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PSMA-Targeted PET Imaging Agent
10.3 Manufacturing Process Analysis of PSMA-Targeted PET Imaging Agent
10.4 Industry Chain Structure of PSMA-Targeted PET Imaging Agent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PSMA-Targeted PET Imaging Agent Distributors
11.3 PSMA-Targeted PET Imaging Agent Customer
12 WORLD FORECAST REVIEW FOR PSMA-TARGETED PET IMAGING AGENT BY GEOGRAPHIC REGION
12.1 Global PSMA-Targeted PET Imaging Agent Market Size Forecast by Region
12.1.1 Global PSMA-Targeted PET Imaging Agent Forecast by Region (2027-2032)
12.1.2 Global PSMA-Targeted PET Imaging Agent Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global PSMA-Targeted PET Imaging Agent Forecast by Type (2027-2032)
12.7 Global PSMA-Targeted PET Imaging Agent Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Lantheus
13.1.1 Lantheus Company Information
13.1.2 Lantheus PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.1.3 Lantheus PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Lantheus Main Business Overview
13.1.5 Lantheus Latest Developments
13.2 Telix Pharmaceuticals
13.2.1 Telix Pharmaceuticals Company Information
13.2.2 Telix Pharmaceuticals PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.2.3 Telix Pharmaceuticals PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Telix Pharmaceuticals Main Business Overview
13.2.5 Telix Pharmaceuticals Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.3.3 Novartis PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Blue Earth Diagnostics?Bracco?
13.4.1 Blue Earth Diagnostics?Bracco? Company Information
13.4.2 Blue Earth Diagnostics?Bracco? PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.4.3 Blue Earth Diagnostics?Bracco? PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Blue Earth Diagnostics?Bracco? Main Business Overview
13.4.5 Blue Earth Diagnostics?Bracco? Latest Developments
13.5 Sinotau
13.5.1 Sinotau Company Information
13.5.2 Sinotau PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.5.3 Sinotau PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sinotau Main Business Overview
13.5.5 Sinotau Latest Developments
13.6 DC PHARMA
13.6.1 DC PHARMA Company Information
13.6.2 DC PHARMA PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.6.3 DC PHARMA PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 DC PHARMA Main Business Overview
13.6.5 DC PHARMA Latest Developments
13.7 Clarity Pharmaceuticals
13.7.1 Clarity Pharmaceuticals Company Information
13.7.2 Clarity Pharmaceuticals PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.7.3 Clarity Pharmaceuticals PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Clarity Pharmaceuticals Main Business Overview
13.7.5 Clarity Pharmaceuticals Latest Developments
13.8 Hengrui Pharma
13.8.1 Hengrui Pharma Company Information
13.8.2 Hengrui Pharma PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.8.3 Hengrui Pharma PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hengrui Pharma Main Business Overview
13.8.5 Hengrui Pharma Latest Developments
13.9 CRAND PHARMACEUTICAL
13.9.1 CRAND PHARMACEUTICAL Company Information
13.9.2 CRAND PHARMACEUTICAL PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.9.3 CRAND PHARMACEUTICAL PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 CRAND PHARMACEUTICAL Main Business Overview
13.9.5 CRAND PHARMACEUTICAL Latest Developments
13.10 Norroy Bioscience
13.10.1 Norroy Bioscience Company Information
13.10.2 Norroy Bioscience PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.10.3 Norroy Bioscience PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Norroy Bioscience Main Business Overview
13.10.5 Norroy Bioscience Latest Developments
13.11 HUAYI RADIOPHARMACEUTICALS
13.11.1 HUAYI RADIOPHARMACEUTICALS Company Information
13.11.2 HUAYI RADIOPHARMACEUTICALS PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.11.3 HUAYI RADIOPHARMACEUTICALS PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 HUAYI RADIOPHARMACEUTICALS Main Business Overview
13.11.5 HUAYI RADIOPHARMACEUTICALS Latest Developments
13.12 Yunhe Pharma
13.12.1 Yunhe Pharma Company Information
13.12.2 Yunhe Pharma PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.12.3 Yunhe Pharma PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Yunhe Pharma Main Business Overview
13.12.5 Yunhe Pharma Latest Developments
13.13 C Ray Therapeutics
13.13.1 C Ray Therapeutics Company Information
13.13.2 C Ray Therapeutics PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.13.3 C Ray Therapeutics PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 C Ray Therapeutics Main Business Overview
13.13.5 C Ray Therapeutics Latest Developments
13.14 Curium Holding France S.A.S.
13.14.1 Curium Holding France S.A.S. Company Information
13.14.2 Curium Holding France S.A.S. PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.14.3 Curium Holding France S.A.S. PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Curium Holding France S.A.S. Main Business Overview
13.14.5 Curium Holding France S.A.S. Latest Developments
13.15 ABX advanced biochemical compounds GmbH
13.15.1 ABX advanced biochemical compounds GmbH Company Information
13.15.2 ABX advanced biochemical compounds GmbH PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.15.3 ABX advanced biochemical compounds GmbH PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 ABX advanced biochemical compounds GmbH Main Business Overview
13.15.5 ABX advanced biochemical compounds GmbH Latest Developments
13.16 Isotopia Molecular Imaging Ltd.
13.16.1 Isotopia Molecular Imaging Ltd. Company Information
13.16.2 Isotopia Molecular Imaging Ltd. PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.16.3 Isotopia Molecular Imaging Ltd. PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Isotopia Molecular Imaging Ltd. Main Business Overview
13.16.5 Isotopia Molecular Imaging Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PSMA-Targeted PET Imaging Agent Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for PSMA-Targeted PET Imaging Agent by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for PSMA-Targeted PET Imaging Agent by Country/Region, 2021, 2025 & 2032
2.2 PSMA-Targeted PET Imaging Agent Segment by Type
2.2.1 68Ga
2.2.2 18F
2.2.3 PSMA-Targeted PET Imaging Agent Sales by Type
2.2.3.1 Global PSMA-Targeted PET Imaging Agent Sales Market Share by Type (2021-2026)
2.2.3.2 Global PSMA-Targeted PET Imaging Agent Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global PSMA-Targeted PET Imaging Agent Sale Price by Type (2021-2026)
2.3 PSMA-Targeted PET Imaging Agent Segment by Core Carrier Materials
2.3.1 First Generation
2.3.2 Second Generation
2.3.3 PSMA-Targeted PET Imaging Agent Sales by Core Carrier Materials
2.3.3.1 Global PSMA-Targeted PET Imaging Agent Sales Market Share by Core Carrier Materials (2021-2026)
2.3.3.2 Global PSMA-Targeted PET Imaging Agent Revenue and Market Share by Core Carrier Materials (2021-2026)
2.3.3.3 Global PSMA-Targeted PET Imaging Agent Sale Price by Core Carrier Materials (2021-2026)
2.4 PSMA-Targeted PET Imaging Agent Segment by Mechanism of Action
2.4.1 Active Targeting
2.4.2 Passive Targeting
2.4.3 PSMA-Targeted PET Imaging Agent Sales by Mechanism of Action
2.4.3.1 Global PSMA-Targeted PET Imaging Agent Sales Market Share by Mechanism of Action (2021-2026)
2.4.3.2 Global PSMA-Targeted PET Imaging Agent Revenue and Market Share by Mechanism of Action (2021-2026)
2.4.3.3 Global PSMA-Targeted PET Imaging Agent Sale Price by Mechanism of Action (2021-2026)
2.5 PSMA-Targeted PET Imaging Agent Segment by Application
2.5.1 Nuclear Medicine and Molecular Imaging
2.5.2 Precision Oncology Diagnostics
2.5.3 Radiopharmaceuticals and Radiopharmaceuticals
2.5.4 PSMA-Targeted PET Imaging Agent Sales by Application
2.5.4.1 Global PSMA-Targeted PET Imaging Agent Sale Market Share by Application (2021-2026)
2.5.4.2 Global PSMA-Targeted PET Imaging Agent Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global PSMA-Targeted PET Imaging Agent Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global PSMA-Targeted PET Imaging Agent Breakdown Data by Company
3.1.1 Global PSMA-Targeted PET Imaging Agent Annual Sales by Company (2021-2026)
3.1.2 Global PSMA-Targeted PET Imaging Agent Sales Market Share by Company (2021-2026)
3.2 Global PSMA-Targeted PET Imaging Agent Annual Revenue by Company (2021-2026)
3.2.1 Global PSMA-Targeted PET Imaging Agent Revenue by Company (2021-2026)
3.2.2 Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Company (2021-2026)
3.3 Global PSMA-Targeted PET Imaging Agent Sale Price by Company
3.4 Key Manufacturers PSMA-Targeted PET Imaging Agent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PSMA-Targeted PET Imaging Agent Product Location Distribution
3.4.2 Players PSMA-Targeted PET Imaging Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PSMA-TARGETED PET IMAGING AGENT BY GEOGRAPHIC REGION
4.1 World Historic PSMA-Targeted PET Imaging Agent Market Size by Geographic Region (2021-2026)
4.1.1 Global PSMA-Targeted PET Imaging Agent Annual Sales by Geographic Region (2021-2026)
4.1.2 Global PSMA-Targeted PET Imaging Agent Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic PSMA-Targeted PET Imaging Agent Market Size by Country/Region (2021-2026)
4.2.1 Global PSMA-Targeted PET Imaging Agent Annual Sales by Country/Region (2021-2026)
4.2.2 Global PSMA-Targeted PET Imaging Agent Annual Revenue by Country/Region (2021-2026)
4.3 Americas PSMA-Targeted PET Imaging Agent Sales Growth
4.4 APAC PSMA-Targeted PET Imaging Agent Sales Growth
4.5 Europe PSMA-Targeted PET Imaging Agent Sales Growth
4.6 Middle East & Africa PSMA-Targeted PET Imaging Agent Sales Growth
5 AMERICAS
5.1 Americas PSMA-Targeted PET Imaging Agent Sales by Country
5.1.1 Americas PSMA-Targeted PET Imaging Agent Sales by Country (2021-2026)
5.1.2 Americas PSMA-Targeted PET Imaging Agent Revenue by Country (2021-2026)
5.2 Americas PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026)
5.3 Americas PSMA-Targeted PET Imaging Agent Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PSMA-Targeted PET Imaging Agent Sales by Region
6.1.1 APAC PSMA-Targeted PET Imaging Agent Sales by Region (2021-2026)
6.1.2 APAC PSMA-Targeted PET Imaging Agent Revenue by Region (2021-2026)
6.2 APAC PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026)
6.3 APAC PSMA-Targeted PET Imaging Agent Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PSMA-Targeted PET Imaging Agent by Country
7.1.1 Europe PSMA-Targeted PET Imaging Agent Sales by Country (2021-2026)
7.1.2 Europe PSMA-Targeted PET Imaging Agent Revenue by Country (2021-2026)
7.2 Europe PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026)
7.3 Europe PSMA-Targeted PET Imaging Agent Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PSMA-Targeted PET Imaging Agent by Country
8.1.1 Middle East & Africa PSMA-Targeted PET Imaging Agent Sales by Country (2021-2026)
8.1.2 Middle East & Africa PSMA-Targeted PET Imaging Agent Revenue by Country (2021-2026)
8.2 Middle East & Africa PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026)
8.3 Middle East & Africa PSMA-Targeted PET Imaging Agent Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PSMA-Targeted PET Imaging Agent
10.3 Manufacturing Process Analysis of PSMA-Targeted PET Imaging Agent
10.4 Industry Chain Structure of PSMA-Targeted PET Imaging Agent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PSMA-Targeted PET Imaging Agent Distributors
11.3 PSMA-Targeted PET Imaging Agent Customer
12 WORLD FORECAST REVIEW FOR PSMA-TARGETED PET IMAGING AGENT BY GEOGRAPHIC REGION
12.1 Global PSMA-Targeted PET Imaging Agent Market Size Forecast by Region
12.1.1 Global PSMA-Targeted PET Imaging Agent Forecast by Region (2027-2032)
12.1.2 Global PSMA-Targeted PET Imaging Agent Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global PSMA-Targeted PET Imaging Agent Forecast by Type (2027-2032)
12.7 Global PSMA-Targeted PET Imaging Agent Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Lantheus
13.1.1 Lantheus Company Information
13.1.2 Lantheus PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.1.3 Lantheus PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Lantheus Main Business Overview
13.1.5 Lantheus Latest Developments
13.2 Telix Pharmaceuticals
13.2.1 Telix Pharmaceuticals Company Information
13.2.2 Telix Pharmaceuticals PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.2.3 Telix Pharmaceuticals PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Telix Pharmaceuticals Main Business Overview
13.2.5 Telix Pharmaceuticals Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.3.3 Novartis PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Blue Earth Diagnostics?Bracco?
13.4.1 Blue Earth Diagnostics?Bracco? Company Information
13.4.2 Blue Earth Diagnostics?Bracco? PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.4.3 Blue Earth Diagnostics?Bracco? PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Blue Earth Diagnostics?Bracco? Main Business Overview
13.4.5 Blue Earth Diagnostics?Bracco? Latest Developments
13.5 Sinotau
13.5.1 Sinotau Company Information
13.5.2 Sinotau PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.5.3 Sinotau PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sinotau Main Business Overview
13.5.5 Sinotau Latest Developments
13.6 DC PHARMA
13.6.1 DC PHARMA Company Information
13.6.2 DC PHARMA PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.6.3 DC PHARMA PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 DC PHARMA Main Business Overview
13.6.5 DC PHARMA Latest Developments
13.7 Clarity Pharmaceuticals
13.7.1 Clarity Pharmaceuticals Company Information
13.7.2 Clarity Pharmaceuticals PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.7.3 Clarity Pharmaceuticals PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Clarity Pharmaceuticals Main Business Overview
13.7.5 Clarity Pharmaceuticals Latest Developments
13.8 Hengrui Pharma
13.8.1 Hengrui Pharma Company Information
13.8.2 Hengrui Pharma PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.8.3 Hengrui Pharma PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hengrui Pharma Main Business Overview
13.8.5 Hengrui Pharma Latest Developments
13.9 CRAND PHARMACEUTICAL
13.9.1 CRAND PHARMACEUTICAL Company Information
13.9.2 CRAND PHARMACEUTICAL PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.9.3 CRAND PHARMACEUTICAL PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 CRAND PHARMACEUTICAL Main Business Overview
13.9.5 CRAND PHARMACEUTICAL Latest Developments
13.10 Norroy Bioscience
13.10.1 Norroy Bioscience Company Information
13.10.2 Norroy Bioscience PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.10.3 Norroy Bioscience PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Norroy Bioscience Main Business Overview
13.10.5 Norroy Bioscience Latest Developments
13.11 HUAYI RADIOPHARMACEUTICALS
13.11.1 HUAYI RADIOPHARMACEUTICALS Company Information
13.11.2 HUAYI RADIOPHARMACEUTICALS PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.11.3 HUAYI RADIOPHARMACEUTICALS PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 HUAYI RADIOPHARMACEUTICALS Main Business Overview
13.11.5 HUAYI RADIOPHARMACEUTICALS Latest Developments
13.12 Yunhe Pharma
13.12.1 Yunhe Pharma Company Information
13.12.2 Yunhe Pharma PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.12.3 Yunhe Pharma PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Yunhe Pharma Main Business Overview
13.12.5 Yunhe Pharma Latest Developments
13.13 C Ray Therapeutics
13.13.1 C Ray Therapeutics Company Information
13.13.2 C Ray Therapeutics PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.13.3 C Ray Therapeutics PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 C Ray Therapeutics Main Business Overview
13.13.5 C Ray Therapeutics Latest Developments
13.14 Curium Holding France S.A.S.
13.14.1 Curium Holding France S.A.S. Company Information
13.14.2 Curium Holding France S.A.S. PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.14.3 Curium Holding France S.A.S. PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Curium Holding France S.A.S. Main Business Overview
13.14.5 Curium Holding France S.A.S. Latest Developments
13.15 ABX advanced biochemical compounds GmbH
13.15.1 ABX advanced biochemical compounds GmbH Company Information
13.15.2 ABX advanced biochemical compounds GmbH PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.15.3 ABX advanced biochemical compounds GmbH PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 ABX advanced biochemical compounds GmbH Main Business Overview
13.15.5 ABX advanced biochemical compounds GmbH Latest Developments
13.16 Isotopia Molecular Imaging Ltd.
13.16.1 Isotopia Molecular Imaging Ltd. Company Information
13.16.2 Isotopia Molecular Imaging Ltd. PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
13.16.3 Isotopia Molecular Imaging Ltd. PSMA-Targeted PET Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Isotopia Molecular Imaging Ltd. Main Business Overview
13.16.5 Isotopia Molecular Imaging Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. PSMA-Targeted PET Imaging Agent Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. PSMA-Targeted PET Imaging Agent Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 68Ga
Table 4. Major Players of 18F
Table 5. Global PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 6. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Type (2021-2026)
Table 7. Global PSMA-Targeted PET Imaging Agent Revenue by Type (2021-2026) & ($ million)
Table 8. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Type (2021-2026)
Table 9. Global PSMA-Targeted PET Imaging Agent Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of First Generation
Table 11. Major Players of Second Generation
Table 12. Global PSMA-Targeted PET Imaging Agent Sales by Core Carrier Materials (2021-2026) & (K Units)
Table 13. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Core Carrier Materials (2021-2026)
Table 14. Global PSMA-Targeted PET Imaging Agent Revenue by Core Carrier Materials (2021-2026) & ($ million)
Table 15. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Core Carrier Materials (2021-2026)
Table 16. Global PSMA-Targeted PET Imaging Agent Sale Price by Core Carrier Materials (2021-2026) & (US$/Unit)
Table 17. Major Players of Active Targeting
Table 18. Major Players of Passive Targeting
Table 19. Global PSMA-Targeted PET Imaging Agent Sales by Mechanism of Action (2021-2026) & (K Units)
Table 20. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Mechanism of Action (2021-2026)
Table 21. Global PSMA-Targeted PET Imaging Agent Revenue by Mechanism of Action (2021-2026) & ($ million)
Table 22. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Mechanism of Action (2021-2026)
Table 23. Global PSMA-Targeted PET Imaging Agent Sale Price by Mechanism of Action (2021-2026) & (US$/Unit)
Table 24. Global PSMA-Targeted PET Imaging Agent Sale by Application (2021-2026) & (K Units)
Table 25. Global PSMA-Targeted PET Imaging Agent Sale Market Share by Application (2021-2026)
Table 26. Global PSMA-Targeted PET Imaging Agent Revenue by Application (2021-2026) & ($ million)
Table 27. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Application (2021-2026)
Table 28. Global PSMA-Targeted PET Imaging Agent Sale Price by Application (2021-2026) & (US$/Unit)
Table 29. Global PSMA-Targeted PET Imaging Agent Sales by Company (2021-2026) & (K Units)
Table 30. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Company (2021-2026)
Table 31. Global PSMA-Targeted PET Imaging Agent Revenue by Company (2021-2026) & ($ millions)
Table 32. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Company (2021-2026)
Table 33. Global PSMA-Targeted PET Imaging Agent Sale Price by Company (2021-2026) & (US$/Unit)
Table 34. Key Manufacturers PSMA-Targeted PET Imaging Agent Producing Area Distribution and Sales Area
Table 35. Players PSMA-Targeted PET Imaging Agent Products Offered
Table 36. PSMA-Targeted PET Imaging Agent Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 37. New Products and Potential Entrants
Table 38. Market M&A Activity & Strategy
Table 39. Global PSMA-Targeted PET Imaging Agent Sales by Geographic Region (2021-2026) & (K Units)
Table 40. Global PSMA-Targeted PET Imaging Agent Sales Market Share Geographic Region (2021-2026)
Table 41. Global PSMA-Targeted PET Imaging Agent Revenue by Geographic Region (2021-2026) & ($ millions)
Table 42. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Geographic Region (2021-2026)
Table 43. Global PSMA-Targeted PET Imaging Agent Sales by Country/Region (2021-2026) & (K Units)
Table 44. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Country/Region (2021-2026)
Table 45. Global PSMA-Targeted PET Imaging Agent Revenue by Country/Region (2021-2026) & ($ millions)
Table 46. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Country/Region (2021-2026)
Table 47. Americas PSMA-Targeted PET Imaging Agent Sales by Country (2021-2026) & (K Units)
Table 48. Americas PSMA-Targeted PET Imaging Agent Sales Market Share by Country (2021-2026)
Table 49. Americas PSMA-Targeted PET Imaging Agent Revenue by Country (2021-2026) & ($ millions)
Table 50. Americas PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 51. Americas PSMA-Targeted PET Imaging Agent Sales by Application (2021-2026) & (K Units)
Table 52. APAC PSMA-Targeted PET Imaging Agent Sales by Region (2021-2026) & (K Units)
Table 53. APAC PSMA-Targeted PET Imaging Agent Sales Market Share by Region (2021-2026)
Table 54. APAC PSMA-Targeted PET Imaging Agent Revenue by Region (2021-2026) & ($ millions)
Table 55. APAC PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 56. APAC PSMA-Targeted PET Imaging Agent Sales by Application (2021-2026) & (K Units)
Table 57. Europe PSMA-Targeted PET Imaging Agent Sales by Country (2021-2026) & (K Units)
Table 58. Europe PSMA-Targeted PET Imaging Agent Revenue by Country (2021-2026) & ($ millions)
Table 59. Europe PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 60. Europe PSMA-Targeted PET Imaging Agent Sales by Application (2021-2026) & (K Units)
Table 61. Middle East & Africa PSMA-Targeted PET Imaging Agent Sales by Country (2021-2026) & (K Units)
Table 62. Middle East & Africa PSMA-Targeted PET Imaging Agent Revenue Market Share by Country (2021-2026)
Table 63. Middle East & Africa PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 64. Middle East & Africa PSMA-Targeted PET Imaging Agent Sales by Application (2021-2026) & (K Units)
Table 65. Key Market Drivers & Growth Opportunities of PSMA-Targeted PET Imaging Agent
Table 66. Key Market Challenges & Risks of PSMA-Targeted PET Imaging Agent
Table 67. Key Industry Trends of PSMA-Targeted PET Imaging Agent
Table 68. PSMA-Targeted PET Imaging Agent Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. PSMA-Targeted PET Imaging Agent Distributors List
Table 71. PSMA-Targeted PET Imaging Agent Customer List
Table 72. Global PSMA-Targeted PET Imaging Agent Sales Forecast by Region (2027-2032) & (K Units)
Table 73. Global PSMA-Targeted PET Imaging Agent Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Americas PSMA-Targeted PET Imaging Agent Sales Forecast by Country (2027-2032) & (K Units)
Table 75. Americas PSMA-Targeted PET Imaging Agent Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. APAC PSMA-Targeted PET Imaging Agent Sales Forecast by Region (2027-2032) & (K Units)
Table 77. APAC PSMA-Targeted PET Imaging Agent Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Europe PSMA-Targeted PET Imaging Agent Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Europe PSMA-Targeted PET Imaging Agent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. Middle East & Africa PSMA-Targeted PET Imaging Agent Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Middle East & Africa PSMA-Targeted PET Imaging Agent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Global PSMA-Targeted PET Imaging Agent Sales Forecast by Type (2027-2032) & (K Units)
Table 83. Global PSMA-Targeted PET Imaging Agent Revenue Forecast by Type (2027-2032) & ($ millions)
Table 84. Global PSMA-Targeted PET Imaging Agent Sales Forecast by Application (2027-2032) & (K Units)
Table 85. Global PSMA-Targeted PET Imaging Agent Revenue Forecast by Application (2027-2032) & ($ millions)
Table 86. Lantheus Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 87. Lantheus PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 88. Lantheus PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Lantheus Main Business
Table 90. Lantheus Latest Developments
Table 91. Telix Pharmaceuticals Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 92. Telix Pharmaceuticals PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 93. Telix Pharmaceuticals PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Telix Pharmaceuticals Main Business
Table 95. Telix Pharmaceuticals Latest Developments
Table 96. Novartis Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 97. Novartis PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 98. Novartis PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Novartis Main Business
Table 100. Novartis Latest Developments
Table 101. Blue Earth Diagnostics?Bracco? Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 102. Blue Earth Diagnostics?Bracco? PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 103. Blue Earth Diagnostics?Bracco? PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Blue Earth Diagnostics?Bracco? Main Business
Table 105. Blue Earth Diagnostics?Bracco? Latest Developments
Table 106. Sinotau Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 107. Sinotau PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 108. Sinotau PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Sinotau Main Business
Table 110. Sinotau Latest Developments
Table 111. DC PHARMA Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 112. DC PHARMA PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 113. DC PHARMA PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. DC PHARMA Main Business
Table 115. DC PHARMA Latest Developments
Table 116. Clarity Pharmaceuticals Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 117. Clarity Pharmaceuticals PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 118. Clarity Pharmaceuticals PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Clarity Pharmaceuticals Main Business
Table 120. Clarity Pharmaceuticals Latest Developments
Table 121. Hengrui Pharma Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 122. Hengrui Pharma PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 123. Hengrui Pharma PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Hengrui Pharma Main Business
Table 125. Hengrui Pharma Latest Developments
Table 126. CRAND PHARMACEUTICAL Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 127. CRAND PHARMACEUTICAL PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 128. CRAND PHARMACEUTICAL PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. CRAND PHARMACEUTICAL Main Business
Table 130. CRAND PHARMACEUTICAL Latest Developments
Table 131. Norroy Bioscience Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 132. Norroy Bioscience PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 133. Norroy Bioscience PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Norroy Bioscience Main Business
Table 135. Norroy Bioscience Latest Developments
Table 136. HUAYI RADIOPHARMACEUTICALS Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 137. HUAYI RADIOPHARMACEUTICALS PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 138. HUAYI RADIOPHARMACEUTICALS PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. HUAYI RADIOPHARMACEUTICALS Main Business
Table 140. HUAYI RADIOPHARMACEUTICALS Latest Developments
Table 141. Yunhe Pharma Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 142. Yunhe Pharma PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 143. Yunhe Pharma PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Yunhe Pharma Main Business
Table 145. Yunhe Pharma Latest Developments
Table 146. C Ray Therapeutics Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 147. C Ray Therapeutics PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 148. C Ray Therapeutics PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 149. C Ray Therapeutics Main Business
Table 150. C Ray Therapeutics Latest Developments
Table 151. Curium Holding France S.A.S. Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 152. Curium Holding France S.A.S. PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 153. Curium Holding France S.A.S. PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 154. Curium Holding France S.A.S. Main Business
Table 155. Curium Holding France S.A.S. Latest Developments
Table 156. ABX advanced biochemical compounds GmbH Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 157. ABX advanced biochemical compounds GmbH PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 158. ABX advanced biochemical compounds GmbH PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 159. ABX advanced biochemical compounds GmbH Main Business
Table 160. ABX advanced biochemical compounds GmbH Latest Developments
Table 161. Isotopia Molecular Imaging Ltd. Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 162. Isotopia Molecular Imaging Ltd. PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 163. Isotopia Molecular Imaging Ltd. PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 164. Isotopia Molecular Imaging Ltd. Main Business
Table 165. Isotopia Molecular Imaging Ltd. Latest Developments
Table 1. PSMA-Targeted PET Imaging Agent Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. PSMA-Targeted PET Imaging Agent Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 68Ga
Table 4. Major Players of 18F
Table 5. Global PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 6. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Type (2021-2026)
Table 7. Global PSMA-Targeted PET Imaging Agent Revenue by Type (2021-2026) & ($ million)
Table 8. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Type (2021-2026)
Table 9. Global PSMA-Targeted PET Imaging Agent Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of First Generation
Table 11. Major Players of Second Generation
Table 12. Global PSMA-Targeted PET Imaging Agent Sales by Core Carrier Materials (2021-2026) & (K Units)
Table 13. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Core Carrier Materials (2021-2026)
Table 14. Global PSMA-Targeted PET Imaging Agent Revenue by Core Carrier Materials (2021-2026) & ($ million)
Table 15. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Core Carrier Materials (2021-2026)
Table 16. Global PSMA-Targeted PET Imaging Agent Sale Price by Core Carrier Materials (2021-2026) & (US$/Unit)
Table 17. Major Players of Active Targeting
Table 18. Major Players of Passive Targeting
Table 19. Global PSMA-Targeted PET Imaging Agent Sales by Mechanism of Action (2021-2026) & (K Units)
Table 20. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Mechanism of Action (2021-2026)
Table 21. Global PSMA-Targeted PET Imaging Agent Revenue by Mechanism of Action (2021-2026) & ($ million)
Table 22. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Mechanism of Action (2021-2026)
Table 23. Global PSMA-Targeted PET Imaging Agent Sale Price by Mechanism of Action (2021-2026) & (US$/Unit)
Table 24. Global PSMA-Targeted PET Imaging Agent Sale by Application (2021-2026) & (K Units)
Table 25. Global PSMA-Targeted PET Imaging Agent Sale Market Share by Application (2021-2026)
Table 26. Global PSMA-Targeted PET Imaging Agent Revenue by Application (2021-2026) & ($ million)
Table 27. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Application (2021-2026)
Table 28. Global PSMA-Targeted PET Imaging Agent Sale Price by Application (2021-2026) & (US$/Unit)
Table 29. Global PSMA-Targeted PET Imaging Agent Sales by Company (2021-2026) & (K Units)
Table 30. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Company (2021-2026)
Table 31. Global PSMA-Targeted PET Imaging Agent Revenue by Company (2021-2026) & ($ millions)
Table 32. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Company (2021-2026)
Table 33. Global PSMA-Targeted PET Imaging Agent Sale Price by Company (2021-2026) & (US$/Unit)
Table 34. Key Manufacturers PSMA-Targeted PET Imaging Agent Producing Area Distribution and Sales Area
Table 35. Players PSMA-Targeted PET Imaging Agent Products Offered
Table 36. PSMA-Targeted PET Imaging Agent Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 37. New Products and Potential Entrants
Table 38. Market M&A Activity & Strategy
Table 39. Global PSMA-Targeted PET Imaging Agent Sales by Geographic Region (2021-2026) & (K Units)
Table 40. Global PSMA-Targeted PET Imaging Agent Sales Market Share Geographic Region (2021-2026)
Table 41. Global PSMA-Targeted PET Imaging Agent Revenue by Geographic Region (2021-2026) & ($ millions)
Table 42. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Geographic Region (2021-2026)
Table 43. Global PSMA-Targeted PET Imaging Agent Sales by Country/Region (2021-2026) & (K Units)
Table 44. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Country/Region (2021-2026)
Table 45. Global PSMA-Targeted PET Imaging Agent Revenue by Country/Region (2021-2026) & ($ millions)
Table 46. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Country/Region (2021-2026)
Table 47. Americas PSMA-Targeted PET Imaging Agent Sales by Country (2021-2026) & (K Units)
Table 48. Americas PSMA-Targeted PET Imaging Agent Sales Market Share by Country (2021-2026)
Table 49. Americas PSMA-Targeted PET Imaging Agent Revenue by Country (2021-2026) & ($ millions)
Table 50. Americas PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 51. Americas PSMA-Targeted PET Imaging Agent Sales by Application (2021-2026) & (K Units)
Table 52. APAC PSMA-Targeted PET Imaging Agent Sales by Region (2021-2026) & (K Units)
Table 53. APAC PSMA-Targeted PET Imaging Agent Sales Market Share by Region (2021-2026)
Table 54. APAC PSMA-Targeted PET Imaging Agent Revenue by Region (2021-2026) & ($ millions)
Table 55. APAC PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 56. APAC PSMA-Targeted PET Imaging Agent Sales by Application (2021-2026) & (K Units)
Table 57. Europe PSMA-Targeted PET Imaging Agent Sales by Country (2021-2026) & (K Units)
Table 58. Europe PSMA-Targeted PET Imaging Agent Revenue by Country (2021-2026) & ($ millions)
Table 59. Europe PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 60. Europe PSMA-Targeted PET Imaging Agent Sales by Application (2021-2026) & (K Units)
Table 61. Middle East & Africa PSMA-Targeted PET Imaging Agent Sales by Country (2021-2026) & (K Units)
Table 62. Middle East & Africa PSMA-Targeted PET Imaging Agent Revenue Market Share by Country (2021-2026)
Table 63. Middle East & Africa PSMA-Targeted PET Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 64. Middle East & Africa PSMA-Targeted PET Imaging Agent Sales by Application (2021-2026) & (K Units)
Table 65. Key Market Drivers & Growth Opportunities of PSMA-Targeted PET Imaging Agent
Table 66. Key Market Challenges & Risks of PSMA-Targeted PET Imaging Agent
Table 67. Key Industry Trends of PSMA-Targeted PET Imaging Agent
Table 68. PSMA-Targeted PET Imaging Agent Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. PSMA-Targeted PET Imaging Agent Distributors List
Table 71. PSMA-Targeted PET Imaging Agent Customer List
Table 72. Global PSMA-Targeted PET Imaging Agent Sales Forecast by Region (2027-2032) & (K Units)
Table 73. Global PSMA-Targeted PET Imaging Agent Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Americas PSMA-Targeted PET Imaging Agent Sales Forecast by Country (2027-2032) & (K Units)
Table 75. Americas PSMA-Targeted PET Imaging Agent Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. APAC PSMA-Targeted PET Imaging Agent Sales Forecast by Region (2027-2032) & (K Units)
Table 77. APAC PSMA-Targeted PET Imaging Agent Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Europe PSMA-Targeted PET Imaging Agent Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Europe PSMA-Targeted PET Imaging Agent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. Middle East & Africa PSMA-Targeted PET Imaging Agent Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Middle East & Africa PSMA-Targeted PET Imaging Agent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Global PSMA-Targeted PET Imaging Agent Sales Forecast by Type (2027-2032) & (K Units)
Table 83. Global PSMA-Targeted PET Imaging Agent Revenue Forecast by Type (2027-2032) & ($ millions)
Table 84. Global PSMA-Targeted PET Imaging Agent Sales Forecast by Application (2027-2032) & (K Units)
Table 85. Global PSMA-Targeted PET Imaging Agent Revenue Forecast by Application (2027-2032) & ($ millions)
Table 86. Lantheus Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 87. Lantheus PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 88. Lantheus PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Lantheus Main Business
Table 90. Lantheus Latest Developments
Table 91. Telix Pharmaceuticals Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 92. Telix Pharmaceuticals PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 93. Telix Pharmaceuticals PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Telix Pharmaceuticals Main Business
Table 95. Telix Pharmaceuticals Latest Developments
Table 96. Novartis Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 97. Novartis PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 98. Novartis PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Novartis Main Business
Table 100. Novartis Latest Developments
Table 101. Blue Earth Diagnostics?Bracco? Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 102. Blue Earth Diagnostics?Bracco? PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 103. Blue Earth Diagnostics?Bracco? PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Blue Earth Diagnostics?Bracco? Main Business
Table 105. Blue Earth Diagnostics?Bracco? Latest Developments
Table 106. Sinotau Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 107. Sinotau PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 108. Sinotau PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Sinotau Main Business
Table 110. Sinotau Latest Developments
Table 111. DC PHARMA Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 112. DC PHARMA PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 113. DC PHARMA PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. DC PHARMA Main Business
Table 115. DC PHARMA Latest Developments
Table 116. Clarity Pharmaceuticals Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 117. Clarity Pharmaceuticals PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 118. Clarity Pharmaceuticals PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Clarity Pharmaceuticals Main Business
Table 120. Clarity Pharmaceuticals Latest Developments
Table 121. Hengrui Pharma Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 122. Hengrui Pharma PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 123. Hengrui Pharma PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Hengrui Pharma Main Business
Table 125. Hengrui Pharma Latest Developments
Table 126. CRAND PHARMACEUTICAL Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 127. CRAND PHARMACEUTICAL PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 128. CRAND PHARMACEUTICAL PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. CRAND PHARMACEUTICAL Main Business
Table 130. CRAND PHARMACEUTICAL Latest Developments
Table 131. Norroy Bioscience Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 132. Norroy Bioscience PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 133. Norroy Bioscience PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Norroy Bioscience Main Business
Table 135. Norroy Bioscience Latest Developments
Table 136. HUAYI RADIOPHARMACEUTICALS Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 137. HUAYI RADIOPHARMACEUTICALS PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 138. HUAYI RADIOPHARMACEUTICALS PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. HUAYI RADIOPHARMACEUTICALS Main Business
Table 140. HUAYI RADIOPHARMACEUTICALS Latest Developments
Table 141. Yunhe Pharma Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 142. Yunhe Pharma PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 143. Yunhe Pharma PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Yunhe Pharma Main Business
Table 145. Yunhe Pharma Latest Developments
Table 146. C Ray Therapeutics Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 147. C Ray Therapeutics PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 148. C Ray Therapeutics PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 149. C Ray Therapeutics Main Business
Table 150. C Ray Therapeutics Latest Developments
Table 151. Curium Holding France S.A.S. Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 152. Curium Holding France S.A.S. PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 153. Curium Holding France S.A.S. PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 154. Curium Holding France S.A.S. Main Business
Table 155. Curium Holding France S.A.S. Latest Developments
Table 156. ABX advanced biochemical compounds GmbH Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 157. ABX advanced biochemical compounds GmbH PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 158. ABX advanced biochemical compounds GmbH PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 159. ABX advanced biochemical compounds GmbH Main Business
Table 160. ABX advanced biochemical compounds GmbH Latest Developments
Table 161. Isotopia Molecular Imaging Ltd. Basic Information, PSMA-Targeted PET Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 162. Isotopia Molecular Imaging Ltd. PSMA-Targeted PET Imaging Agent Product Portfolios and Specifications
Table 163. Isotopia Molecular Imaging Ltd. PSMA-Targeted PET Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 164. Isotopia Molecular Imaging Ltd. Main Business
Table 165. Isotopia Molecular Imaging Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of PSMA-Targeted PET Imaging Agent
Figure 2. PSMA-Targeted PET Imaging Agent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PSMA-Targeted PET Imaging Agent Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global PSMA-Targeted PET Imaging Agent Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. PSMA-Targeted PET Imaging Agent Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. PSMA-Targeted PET Imaging Agent Sales Market Share by Country/Region (2025)
Figure 10. PSMA-Targeted PET Imaging Agent Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 68Ga
Figure 12. Product Picture of 18F
Figure 13. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Type in 2026
Figure 14. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of First Generation
Figure 16. Product Picture of Second Generation
Figure 17. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Core Carrier Materials in 2026
Figure 18. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Core Carrier Materials (2021-2026)
Figure 19. Product Picture of Active Targeting
Figure 20. Product Picture of Passive Targeting
Figure 21. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Mechanism of Action in 2026
Figure 22. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Mechanism of Action (2021-2026)
Figure 23. PSMA-Targeted PET Imaging Agent Consumed in Nuclear Medicine and Molecular Imaging
Figure 24. Global PSMA-Targeted PET Imaging Agent Market: Nuclear Medicine and Molecular Imaging (2021-2026) & (K Units)
Figure 25. PSMA-Targeted PET Imaging Agent Consumed in Precision Oncology Diagnostics
Figure 26. Global PSMA-Targeted PET Imaging Agent Market: Precision Oncology Diagnostics (2021-2026) & (K Units)
Figure 27. PSMA-Targeted PET Imaging Agent Consumed in Radiopharmaceuticals and Radiopharmaceuticals
Figure 28. Global PSMA-Targeted PET Imaging Agent Market: Radiopharmaceuticals and Radiopharmaceuticals (2021-2026) & (K Units)
Figure 29. Global PSMA-Targeted PET Imaging Agent Sale Market Share by Application (2025)
Figure 30. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Application in 2025
Figure 31. PSMA-Targeted PET Imaging Agent Sales by Company in 2025 (K Units)
Figure 32. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Company in 2025
Figure 33. PSMA-Targeted PET Imaging Agent Revenue by Company in 2025 ($ millions)
Figure 34. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Company in 2025
Figure 35. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Geographic Region in 2025
Figure 37. Americas PSMA-Targeted PET Imaging Agent Sales 2021-2026 (K Units)
Figure 38. Americas PSMA-Targeted PET Imaging Agent Revenue 2021-2026 ($ millions)
Figure 39. APAC PSMA-Targeted PET Imaging Agent Sales 2021-2026 (K Units)
Figure 40. APAC PSMA-Targeted PET Imaging Agent Revenue 2021-2026 ($ millions)
Figure 41. Europe PSMA-Targeted PET Imaging Agent Sales 2021-2026 (K Units)
Figure 42. Europe PSMA-Targeted PET Imaging Agent Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa PSMA-Targeted PET Imaging Agent Sales 2021-2026 (K Units)
Figure 44. Middle East & Africa PSMA-Targeted PET Imaging Agent Revenue 2021-2026 ($ millions)
Figure 45. Americas PSMA-Targeted PET Imaging Agent Sales Market Share by Country in 2025
Figure 46. Americas PSMA-Targeted PET Imaging Agent Revenue Market Share by Country (2021-2026)
Figure 47. Americas PSMA-Targeted PET Imaging Agent Sales Market Share by Type (2021-2026)
Figure 48. Americas PSMA-Targeted PET Imaging Agent Sales Market Share by Application (2021-2026)
Figure 49. United States PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC PSMA-Targeted PET Imaging Agent Sales Market Share by Region in 2025
Figure 54. APAC PSMA-Targeted PET Imaging Agent Revenue Market Share by Region (2021-2026)
Figure 55. APAC PSMA-Targeted PET Imaging Agent Sales Market Share by Type (2021-2026)
Figure 56. APAC PSMA-Targeted PET Imaging Agent Sales Market Share by Application (2021-2026)
Figure 57. China PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 61. India PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe PSMA-Targeted PET Imaging Agent Sales Market Share by Country in 2025
Figure 65. Europe PSMA-Targeted PET Imaging Agent Revenue Market Share by Country (2021-2026)
Figure 66. Europe PSMA-Targeted PET Imaging Agent Sales Market Share by Type (2021-2026)
Figure 67. Europe PSMA-Targeted PET Imaging Agent Sales Market Share by Application (2021-2026)
Figure 68. Germany PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 69. France PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 70. UK PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa PSMA-Targeted PET Imaging Agent Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa PSMA-Targeted PET Imaging Agent Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa PSMA-Targeted PET Imaging Agent Sales Market Share by Application (2021-2026)
Figure 76. Egypt PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of PSMA-Targeted PET Imaging Agent in 2026
Figure 82. Manufacturing Process Analysis of PSMA-Targeted PET Imaging Agent
Figure 83. Industry Chain Structure of PSMA-Targeted PET Imaging Agent
Figure 84. Channels of Distribution
Figure 85. Global PSMA-Targeted PET Imaging Agent Sales Market Forecast by Region (2027-2032)
Figure 86. Global PSMA-Targeted PET Imaging Agent Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global PSMA-Targeted PET Imaging Agent Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global PSMA-Targeted PET Imaging Agent Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global PSMA-Targeted PET Imaging Agent Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global PSMA-Targeted PET Imaging Agent Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of PSMA-Targeted PET Imaging Agent
Figure 2. PSMA-Targeted PET Imaging Agent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PSMA-Targeted PET Imaging Agent Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global PSMA-Targeted PET Imaging Agent Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. PSMA-Targeted PET Imaging Agent Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. PSMA-Targeted PET Imaging Agent Sales Market Share by Country/Region (2025)
Figure 10. PSMA-Targeted PET Imaging Agent Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 68Ga
Figure 12. Product Picture of 18F
Figure 13. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Type in 2026
Figure 14. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of First Generation
Figure 16. Product Picture of Second Generation
Figure 17. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Core Carrier Materials in 2026
Figure 18. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Core Carrier Materials (2021-2026)
Figure 19. Product Picture of Active Targeting
Figure 20. Product Picture of Passive Targeting
Figure 21. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Mechanism of Action in 2026
Figure 22. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Mechanism of Action (2021-2026)
Figure 23. PSMA-Targeted PET Imaging Agent Consumed in Nuclear Medicine and Molecular Imaging
Figure 24. Global PSMA-Targeted PET Imaging Agent Market: Nuclear Medicine and Molecular Imaging (2021-2026) & (K Units)
Figure 25. PSMA-Targeted PET Imaging Agent Consumed in Precision Oncology Diagnostics
Figure 26. Global PSMA-Targeted PET Imaging Agent Market: Precision Oncology Diagnostics (2021-2026) & (K Units)
Figure 27. PSMA-Targeted PET Imaging Agent Consumed in Radiopharmaceuticals and Radiopharmaceuticals
Figure 28. Global PSMA-Targeted PET Imaging Agent Market: Radiopharmaceuticals and Radiopharmaceuticals (2021-2026) & (K Units)
Figure 29. Global PSMA-Targeted PET Imaging Agent Sale Market Share by Application (2025)
Figure 30. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Application in 2025
Figure 31. PSMA-Targeted PET Imaging Agent Sales by Company in 2025 (K Units)
Figure 32. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Company in 2025
Figure 33. PSMA-Targeted PET Imaging Agent Revenue by Company in 2025 ($ millions)
Figure 34. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Company in 2025
Figure 35. Global PSMA-Targeted PET Imaging Agent Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global PSMA-Targeted PET Imaging Agent Revenue Market Share by Geographic Region in 2025
Figure 37. Americas PSMA-Targeted PET Imaging Agent Sales 2021-2026 (K Units)
Figure 38. Americas PSMA-Targeted PET Imaging Agent Revenue 2021-2026 ($ millions)
Figure 39. APAC PSMA-Targeted PET Imaging Agent Sales 2021-2026 (K Units)
Figure 40. APAC PSMA-Targeted PET Imaging Agent Revenue 2021-2026 ($ millions)
Figure 41. Europe PSMA-Targeted PET Imaging Agent Sales 2021-2026 (K Units)
Figure 42. Europe PSMA-Targeted PET Imaging Agent Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa PSMA-Targeted PET Imaging Agent Sales 2021-2026 (K Units)
Figure 44. Middle East & Africa PSMA-Targeted PET Imaging Agent Revenue 2021-2026 ($ millions)
Figure 45. Americas PSMA-Targeted PET Imaging Agent Sales Market Share by Country in 2025
Figure 46. Americas PSMA-Targeted PET Imaging Agent Revenue Market Share by Country (2021-2026)
Figure 47. Americas PSMA-Targeted PET Imaging Agent Sales Market Share by Type (2021-2026)
Figure 48. Americas PSMA-Targeted PET Imaging Agent Sales Market Share by Application (2021-2026)
Figure 49. United States PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC PSMA-Targeted PET Imaging Agent Sales Market Share by Region in 2025
Figure 54. APAC PSMA-Targeted PET Imaging Agent Revenue Market Share by Region (2021-2026)
Figure 55. APAC PSMA-Targeted PET Imaging Agent Sales Market Share by Type (2021-2026)
Figure 56. APAC PSMA-Targeted PET Imaging Agent Sales Market Share by Application (2021-2026)
Figure 57. China PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 61. India PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe PSMA-Targeted PET Imaging Agent Sales Market Share by Country in 2025
Figure 65. Europe PSMA-Targeted PET Imaging Agent Revenue Market Share by Country (2021-2026)
Figure 66. Europe PSMA-Targeted PET Imaging Agent Sales Market Share by Type (2021-2026)
Figure 67. Europe PSMA-Targeted PET Imaging Agent Sales Market Share by Application (2021-2026)
Figure 68. Germany PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 69. France PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 70. UK PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa PSMA-Targeted PET Imaging Agent Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa PSMA-Targeted PET Imaging Agent Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa PSMA-Targeted PET Imaging Agent Sales Market Share by Application (2021-2026)
Figure 76. Egypt PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries PSMA-Targeted PET Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of PSMA-Targeted PET Imaging Agent in 2026
Figure 82. Manufacturing Process Analysis of PSMA-Targeted PET Imaging Agent
Figure 83. Industry Chain Structure of PSMA-Targeted PET Imaging Agent
Figure 84. Channels of Distribution
Figure 85. Global PSMA-Targeted PET Imaging Agent Sales Market Forecast by Region (2027-2032)
Figure 86. Global PSMA-Targeted PET Imaging Agent Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global PSMA-Targeted PET Imaging Agent Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global PSMA-Targeted PET Imaging Agent Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global PSMA-Targeted PET Imaging Agent Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global PSMA-Targeted PET Imaging Agent Revenue Market Share Forecast by Application (2027-2032)
